Events
MOSAIC – the Global NASH/MASH Trialist Forum
24-25 October 2024
Washington DC, USA
ENYO Pharma is attending the MOSAIC – Global NASH Trialist Forum 2024. The goal of the meeting was to define new integrative Cardiovascular-Kidney-Liver-Metabolic (CKLM) trials together with cardiology, endocrinology & hepatology clinical trialists, industry, regulatory experts, payers, patients representatives and other stakeholders.
ASN Kidney Week 2024
23-27 October 2024
San Diego, CA
ENYO Pharma will attend the world’s premier nephrology meeting of the American Society of Nephrology, ASN Kidney Week.
https://www.asn-online.org/education/kidneyweek/2024/important-dates.aspx
FEDERG meeting – Federation of European Patient Groups affected by Rare/Genetic Kidney Diseases
14 September 2024
Martorell, Spain
The Federation of European Patient Groups affected by Rare/Genetic Kidney Diseases, FEDERG, was organising its “fighting for our federation Federg f2f Members” meeting on the 14th of September in Martorell in Spain. The objective of the meeting was to plan new practical actions that help improve and promote knowledge of these pathologies, promote research, and be an active part in the political decision-making process for the inclusion of our pathologies.
Alport Connect 2024, the annual Alport syndrome patient and family meeting in US
27-28 July 2024
Denver, CA
ENYO Pharma is sponsoring and will attend Alport Connect 2024 organized by the American Alport Syndrome Foundation (ASF), the Alport syndrome patient-led non-profit organization in the US.
ENYO Pharma will meet patients and their families to present its starting Phase 2 “ALPESTRIA-1” clinical study with Vonafexor in Alport syndrome patients.
6th CKD Summit – Chronic Kidney Disease Drug Development
19-21 March, 2024
Boston, MA
ENYO Pharma will attend the 6th Chronic Kidney Disease Drug Development Summit, an industry forum sharing cross-industry insight to bring effective therapies to patients suffering from kidney diseases expanding also to rare renal disorders.
Latest Press Release 